Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelique Hoelzemer

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|June 17, 2022
NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune ResponsesLeonore Mensching, Angelique Hoelzemer
Current Opinion in HIV and AIDS|August 20, 2025
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearanceKatharina Schiering, Maya Beiersdorfer, Angelique Hoelzemer
Nature Microbiology|September 22, 2025
A transatlantic joint lab model for interdisciplinary researchAngelique Hoelzemer, Wilfredo F Garcia-Beltran
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 7, 2026
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovirSophie Post, Mohamed Zamzamy, Luca Benthien, et al.
Nature Communications|April 26, 2024
Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
Nature Communications|May 21, 2024
Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
Oncoimmunology|August 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patientsJoao Gorgulho, Timo Trenkner, Eva Kinkel, et al.
EMBO Reports|June 27, 2022
Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cellsJohannes Höfle, Timo Trenkner, Nadja Kleist, et al.
British Journal of Pharmacology|November 28, 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovirMohamed Zamzamy, Sophie Post, Wing Hang Ip, et al.
Iscience|July 18, 2025
HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine productionLeonore Mensching, Maya Beiersdorfer, Sebastian Schloer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|June 17, 2022
NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune ResponsesLeonore Mensching, Angelique Hoelzemer
Current Opinion in HIV and AIDS|August 20, 2025
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearanceKatharina Schiering, Maya Beiersdorfer, Angelique Hoelzemer
Nature Microbiology|September 22, 2025
A transatlantic joint lab model for interdisciplinary researchAngelique Hoelzemer, Wilfredo F Garcia-Beltran
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 7, 2026
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovirSophie Post, Mohamed Zamzamy, Luca Benthien, et al.
Nature Communications|April 26, 2024
Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
Nature Communications|May 21, 2024
Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
Oncoimmunology|August 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patientsJoao Gorgulho, Timo Trenkner, Eva Kinkel, et al.
EMBO Reports|June 27, 2022
Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cellsJohannes Höfle, Timo Trenkner, Nadja Kleist, et al.
British Journal of Pharmacology|November 28, 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovirMohamed Zamzamy, Sophie Post, Wing Hang Ip, et al.
Iscience|July 18, 2025
HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine productionLeonore Mensching, Maya Beiersdorfer, Sebastian Schloer, et al.
Pageof 2